... Dystrophy AssociationEstimation of Clinical Trial Success Rates and Related Parameters — BiostatisticsLearning About Clinical Trials — Cure SMAPublic Workshop: Evaluating Inclusion and Exclusion Criteria in Clinical Trials (Workshop Report) — U.S. ...
How Do Clinical Trials Work for SMA?
... Dystrophy AssociationEstimation of Clinical Trial Success Rates and Related Parameters — BiostatisticsLearning About Clinical Trials — Cure SMAPublic Workshop: Evaluating Inclusion and Exclusion Criteria in Clinical Trials (Workshop Report) — U.S. ...
... — BMJClinical Trials — University of Rochester Medical Center ...
... Clinical Trials Help Others by Advancing ResearchPeople with SMA participate in clinical trials for a variety of reasons, not least of which is to contribute to research that can potentially help others. ...
... Phase 3 SAPPHIRE Clinical Trial Evaluating Apitegromab in Non-Ambulatory Patients with Type 2 and Type 3 Spinal Muscular Atrophy (SMA) — Scholar Rock Phase 3 Active Treatment Trial To Evaluate the Efficacy and Safety of Apitegromab in Patients With Later-Onset Spinal Muscular Atrophy Who Are Being Treated With Nusinersen or Risdiplam (SAPPHIRE) — ClinicalTrials.gov ...
Posted 12/22/2021
Participants Sought for Clinical Trial of SMA Muscle Therapy Apitegromab
... Phase 3 SAPPHIRE Clinical Trial Evaluating Apitegromab in Non-Ambulatory Patients with Type 2 and Type 3 Spinal Muscular Atrophy (SMA) — Scholar Rock Phase 3 Active Treatment Trial To Evaluate the Efficacy and Safety of Apitegromab in Patients With Later-Onset Spinal Muscular Atrophy Who Are Being Treated With Nusinersen or Risdiplam (SAPPHIRE) — ClinicalTrials.gov ...
Posted 12/22/2021
... References Biohaven Commences Phase 3 Study of Taldefgrobep Alfa in Spinal Muscular Atrophy — NeurologyLive Spinal Muscular Atrophy — MedlinePlus NeuroVoices: Lindsay Lee Lair, MD, on the Phase 3 RESILIENT Trial of Taldefgropeb Alfa in SMA — NeurologyLive NIH Clinical Research Trials and You — National Institutes of Health A Study to Evaluate the Efficacy ...
Posted 08/17/2022
Study Recruiting for New Add-On SMA Treatment
... References Biohaven Commences Phase 3 Study of Taldefgrobep Alfa in Spinal Muscular Atrophy — NeurologyLive Spinal Muscular Atrophy — MedlinePlus NeuroVoices: Lindsay Lee Lair, MD, on the Phase 3 RESILIENT Trial of Taldefgropeb Alfa in SMA — NeurologyLive NIH Clinical Research Trials and You — National Institutes of Health A Study to Evaluate the Efficacy ...
Posted 08/17/2022
... His research expertise is developing outcome measurement tools for pharmaceutical trials. Dr. Heatwole focuses on SMA, as well as other neuromuscular conditions. Dr. Heatwole was also involved in validating the SMA-HI. ...
Posted 09/15/2021
Caregivers Sought for SMA Outcome Tool Validation Study
... His research expertise is developing outcome measurement tools for pharmaceutical trials. Dr. Heatwole focuses on SMA, as well as other neuromuscular conditions. Dr. Heatwole was also involved in validating the SMA-HI. ...
Posted 09/15/2021
... Clinical trials are underway to explore possible new therapies and discover new uses for existing treatments. Researchers are still learning more about SMA and making treatment advances. ...
Posted 11/16/2022
... For most children in Zolgensma clinical trials, liver enzyme levels returned to normal within two months. However, high enzyme levels can sometimes progress to worse liver problems. Out of 43 children treated with Zolgensma outside of clinical trials, two developed liver injury, which was successfully treated. ...
Posted 11/30/2021
SMA Medication Zolgensma May Cause Liver Failure, Warns New Label Update
... For most children in Zolgensma clinical trials, liver enzyme levels returned to normal within two months. However, high enzyme levels can sometimes progress to worse liver problems. Out of 43 children treated with Zolgensma outside of clinical trials, two developed liver injury, which was successfully treated. ...
Posted 11/30/2021
... References Spinal Muscular Atrophy — Orphanet Journal of Rare Diseases Spinal Muscular Atrophy — JAMA Neurology Spinal Muscular Atrophy — Medline Plus Newborn Screening for SMA — Cure SMA The Discovery of SMA — Cure SMA Spinal Muscular Atrophy: Huge Steps — Dana Foundation 2019: SMA Drugs Approved and Clinical Trials — SMA Foundation Spinal Muscular ...
The History of Spinal Muscular Atrophy
... References Spinal Muscular Atrophy — Orphanet Journal of Rare Diseases Spinal Muscular Atrophy — JAMA Neurology Spinal Muscular Atrophy — Medline Plus Newborn Screening for SMA — Cure SMA The Discovery of SMA — Cure SMA Spinal Muscular Atrophy: Huge Steps — Dana Foundation 2019: SMA Drugs Approved and Clinical Trials — SMA Foundation Spinal Muscular ...
... Trials Cardiovascular Diseases (CVDs) — World Health Organization Understanding the Experiences and Needs of Individuals With Spinal Muscular Atrophy and Their Parents: A Qualitative Study — BMC Neurology ...
Join
Your Privacy Choices
